A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The primary purpose of this phase 1, double-blind, cohort study is to evaluate the safety, tolerability, and pharmacokinetics of escalating doses of MGAWN1 administered as a single intravenous (IV) infusion to healthy adults. Subjects will be enrolled sequentially into one of 5 dose-level cohorts, with 8 subjects in each cohort. Six subjects in each cohort will receive MGAWN1 (a Neutralizing, Humanized, Monoclonal Antibody (IgG1k) to West Nile Virus) and 2 will receive a saline control.
Epistemonikos ID: 420f83ad9529e6b6af5e509599d80cc7b102480e
First added on: Mar 23, 2020